Ivermectin (IVM) applied extracellularly increases the sensitivity of P2X4 receptor (P2X4R) to ATP, enhances the maximum current amplitudes, and greatly prolongs the deactivation kinetics. In this manuscript, we focused on identification of receptor-specific residues responsible for IVM effects on channel gating using the wild-type rat homomeric P2X4R, several chimeric P2X2/P2X4 receptors, and single-point P2X4R-specific mutants in the ectodomain and two transmembrane domains. Experiments with chimeric receptors revealed that the Val49-Val61 but not the Val64-Tyr315 ectodomain sequence is important for the effects of IVM on channel deactivation. Receptor-specific mutations placed in the Gly29-Val61 and Asp338-Leu358 regions showed the importance of Trp50, Val60, and Val357 residues in IVM regulation of the rate of channel deactivation, but not on the maximum current amplitude. These results suggest that the transmembrane domains and the nearby ectodomain region contribute to the effects of IVM on channel deactivation.

Department of Cellular and Molecular Neuroendocrinology Institute of Physiology ASCR Prague Czech Republic

References provided by Crossref.org

Cell Type-Specific Expression of Purinergic P2X Receptors in the Hypothalamus

Deciphering the regulation of P2X4 receptor channel gating by ivermectin using Markov models

Allosteric regulation of the P2X4 receptor channel pore dilation

Identification of functionally important residues of the rat P2X4 receptor by alanine scanning mutagenesis of the dorsal fin and left flipper domains

Multiple roles of the extracellular vestibule amino acid residues in the function of the rat P2X4 receptor

Roles of conserved ectodomain cysteines of the rat P2X4 purinoreceptor in agonist binding and channel gating

Functional relevance of aromatic residues in the first transmembrane domain of P2X receptors

Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin